Publications

A next-generation HDAC6 inhibitor for amyotrophic lateral sclerosis and frontotemporal dementia

 47
A next-generation HDAC6 inhibitor for amyotrophic lateral sclerosis and frontotemporal dementia

Tags:

Previous Article

Monitoring dynamic single-cell events using noninvasive methods

Next Article

A next-generation HDAC6 inhibitor for ALS treatment

Related Posts

Initiation of lumen formation from junctions via differential actomyosin contractility regulated by dynamic recruitment of Rasip1

Initiation of lumen formation from junctions via differ...

 118

RNA targeting therapy for a prenatally enriched potassium channel associated with severe childhood epilepsy and premature death

RNA targeting therapy for a prenatally enriched potassi...

 29

Altered GM1 catabolism affects NMDAR-mediated Ca2+ signaling at ER-PM junctions and increases synaptic spine formation in a GM1-gangliosidosis model

Altered GM1 catabolism affects NMDAR-mediated Ca2+ sign...

 129